About OncoTracker

About company

OncoTracker is an incubator for cancer treatment innovations with a focus on the diagnosis and treatment of multiple myeloma, other B-cell malignancies, and related disorders. It is based on measuring B-cell maturation antigen (BCMA) and helps in monitoring and predicting outcomes for multiple myeloma and chronic lymphocytic leukemia patients, making it possible to more rapidly and accurately assess changes in a patient's cancer and further predict treatment efficacy.